The KCNH3 inhibitor ASP2905 shows potential in the treatment of attention deficit/hyperactivity disorder
Fig 2
Effect of ASP2905 (A) and methylphenidate (B) on cumulative latency in the 5-trial passive avoidance task administered to juvenile SHRSP. Cumulative latency data are expressed as the mean ± SEM. The numbers in parentheses indicate the number of rats in each group. *p <0.05, **p <0.01 vs the vehicle-treated SHRSP group (Dunnett’s test); ##p <0.01 vs the WKY group (Student t test).